CA
VCEL icon

CastleArk Alternatives’s Vericel Corp VCEL Stock Holding History

CastleArk Alternatives’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-153,160
Closed -$7.47M – 281
2021
Q3 		$7.47M Buy
+153,160
New +$7.93M 0.29% 94

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CastleArk Alternatives's VCEL Position: Q4 2021 in Review

CastleArk Alternatives sold out of Vericel Corp (VCEL) in Q4 2021, closing a stake of 153,160 shares — an estimated $7.47M sold.

CastleArk Alternatives first reported a position in VCEL in Q3 2021 and held it in 1 quarter. The position peaked at $7.47M in Q3 2021. 185 funds tracked by Wall St. Rank hold VCEL as of Q4 2021.

  • CastleArk Alternatives reported no remaining Vericel Corp position as of Q4 2021 after selling out during the quarter.
  • CastleArk Alternatives sold 153,160 Vericel Corp shares in Q4 2021, an estimated $7.47M.
  • CastleArk Alternatives first reported a position in Vericel Corp in Q3 2021 and held it in 1 quarter.
  • CastleArk Alternatives's Vericel Corp position peaked at $7.47M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.